Pharmaceutical compositions comprising at least one protein kinase inhibitor and at least one stable amorphous hybrid nanoparticles of polymeric stabilizing matrix forming components
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water soluble drugs. In particular, the present invention relates to stable amorphous hybrid nanoparticles comprising at least one protein kinase inhibitor and at least one polymeric stabilizing matrix-forming component useful in pharmaceutical compositions and therapies. It is related with the composition containing.本発明は、難水溶性薬物を含む医薬組成物を提供する方法の分野に関する。詳細には、本発明は、医薬組成物及び療法において有用な、少なくとも1種のプロテインキナーゼ阻害剤及び少なくとも1種のポリマー性安定化マトリックス形成性成分を含む安定な非晶質のハイブリッドナノ粒子を含む組成物に関する。